Warnock Louise, Gates Alison
Oxford Adult Cystic Fibrosis Centre, Oxford Centre for Respiratory Medicine, The Churchill Hospital, Old Road, Headington, Oxford, UK, OX3 7LJ.
Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD001401. doi: 10.1002/14651858.CD001401.pub3.
Chest physiotherapy is widely used in people with cystic fibrosis in order to clear mucus from the airways. This is an updated version of previously published reviews.
To determine the effectiveness and acceptability of chest physiotherapy compared to no treatment or spontaneous cough alone to improve mucus clearance in cystic fibrosis.
We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.Date of the most recent search of the Group's Cystic Fibrosis Trials Register: 02 June 2015.
Randomised or quasi-randomised clinical studies in which a form of chest physiotherapy (airway clearance technique) were taken for consideration in people with cystic fibrosis compared with either no physiotherapy treatment or spontaneous cough alone.
Both authors independently assessed study eligibility, extracted data and assessed the risk of bias in the included studies. There was heterogeneity in the published outcomes, with variable reporting which meant pooling of the data for meta-analysis was not possible.
The searches identified 157 studies, of which eight cross-over studies (data from 96 participants) met the inclusion criteria. There were differences between studies in the way that interventions were delivered, with several of the intervention groups combining more than one treatment modality. One included study looked at autogenic drainage, six considered conventional chest physiotherapy, three considered oscillating positive expiratory pressure, seven considered positive expiratory pressure and one considered high pressure positive expiratory pressure. Of the eight studies, six were single-treatment studies and in two, the treatment intervention was performed over two consecutive days (once daily in one, twice daily in the other). This enormous heterogeneity in the treatment interventions prevented any meta-analyses from being performed. Blinding of participants, caregivers or clinicians in airway clearance studies is impossible; therefore this was not considered as a high risk of bias in the included studies. Lack of protocol data made assessment of risk of bias unclear for the majority of other criteria.Four studies, involving 28 participants, reported a higher amount of expectorated secretions during chest physiotherapy as compared to a control. One study, involving 18 participants, reported no significant differences in sputum weight. In five studies radioactive tracer clearance was used as an outcome variable. In three of these (28 participants) it was reported that chest physiotherapy, including coughing, increased radioactive tracer clearance as compared to the control period. One study (12 participants) reported increased radioactive tracer clearance associated with all interventions compared to control, although this was only reported to have reached significance for postural drainage with percussion and vibrations; and the remaining study (eight participants) reported no significant difference in radioactive tracer clearance between chest physiotherapy, without coughing, compared to the control period. Three studies, involving 42 participants reported no significant effect on pulmonary function variables following intervention; but one further study did report significant improvement in pulmonary function following the intervention in some of the treatment groups.
AUTHORS' CONCLUSIONS: The results of this review show that airway clearance techniques have short-term effects in the terms of increasing mucus transport. No evidence was found on which to draw conclusions concerning the long-term effects.
胸部物理治疗广泛应用于囊性纤维化患者,以清除气道中的黏液。这是先前发表综述的更新版本。
确定与不治疗或仅自主咳嗽相比,胸部物理治疗在改善囊性纤维化患者黏液清除方面的有效性和可接受性。
我们检索了Cochrane囊性纤维化和遗传疾病小组试验注册库,该注册库包含通过全面电子数据库检索以及对相关期刊和会议论文摘要集进行手工检索而识别的参考文献。该小组囊性纤维化试验注册库的最新检索日期为2015年6月2日。
随机或半随机临床研究,其中将某种形式的胸部物理治疗(气道清除技术)应用于囊性纤维化患者,并与不进行物理治疗或仅自主咳嗽进行比较。
两位作者独立评估研究的合格性,提取数据并评估纳入研究的偏倚风险。已发表的结果存在异质性,报告方式各异,这意味着无法对数据进行汇总以进行荟萃分析。
检索到157项研究,其中八项交叉研究(96名参与者的数据)符合纳入标准。各研究在干预实施方式上存在差异,几个干预组采用了不止一种治疗方式。一项纳入研究关注自体引流,六项考虑传统胸部物理治疗,三项考虑振荡呼气末正压,七项考虑呼气末正压,一项考虑高压呼气末正压。在这八项研究中,六项为单治疗研究,两项中治疗干预连续进行两天(一项每天一次,另一项每天两次)。治疗干预的这种巨大异质性使得无法进行任何荟萃分析。气道清除研究中不可能对参与者、护理人员或临床医生进行盲法;因此,在纳入研究中这未被视为高偏倚风险。由于缺乏方案数据,大多数其他标准的偏倚风险评估不明确。四项研究(涉及28名参与者)报告,与对照组相比,胸部物理治疗期间咳出的分泌物量更多。一项研究(涉及18名参与者)报告痰液重量无显著差异。五项研究将放射性示踪剂清除作为结局变量。其中三项研究(28名参与者)报告,与对照期相比,包括咳嗽在内的胸部物理治疗增加了放射性示踪剂清除。一项研究(12名参与者)报告,与对照组相比,所有干预措施均使放射性示踪剂清除增加,尽管仅报告体位引流加叩击和振动达到显著水平;其余一项研究(8名参与者)报告,不咳嗽的胸部物理治疗与对照期相比,放射性示踪剂清除无显著差异。三项研究(涉及42名参与者)报告干预后对肺功能变量无显著影响;但另一项研究确实报告在一些治疗组中干预后肺功能有显著改善。
本综述结果表明,气道清除技术在增加黏液运输方面有短期效果。未找到可据此得出长期效果结论的证据。